| James C Quigley, MD | |
|
12300 Metcalf Ave, Overland Park, KS 66213-1324 | |
| (816) 241-0928 | |
| (816) 936-8118 |
| Full Name | James C Quigley |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 12300 Metcalf Ave, Overland Park, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235199423 | NPI | - | NPPES |
| 201710316 | Medicaid | MO | |
| 100200800A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 04-20493 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James C Quigley, MD 2750 Clay Edwards Dr, Suite 420, North Kansas City, MO 64116-3237 Ph: (816) 241-0928 | James C Quigley, MD 12300 Metcalf Ave, Overland Park, KS 66213-1324 Ph: (816) 241-0928 |
News Archive
Trubion Pharmaceuticals, Inc. today announced the signing of a definitive merger agreement with Emergent BioSolutions Inc., in which Emergent has agreed to acquire Trubion. Under the terms of the agreement, each share of Trubion common stock will be converted into the right to receive an upfront payment of $1.365 per share in cash and 0.1641 shares of Emergent BioSolutions common stock.
The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, "Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership," to outline a systematic, phased approach to safely reintroducing cardiovascular procedures for diagnosis and treatment during the COVID-19 pandemic.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
Postoperative anemia is associated with longer hospital stays following surgery for hip fracture, Dutch researchers report.
According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.
› Verified 1 days ago
Walter P. Richardson, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 7800 W 110th St, Overland Park, KS 66210 Phone: 913-338-4070 Fax: 913-338-4245 | |
Michael Scott Handler, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 12408 Russell St, Overland Park, KS 66209 Phone: 913-498-3600 Fax: 913-498-3601 | |
Dr. Xiao Meng Xu, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 7301 College Blvd, Ste. 110, Overland Park, KS 66210 Phone: 913-341-6297 Fax: 913-341-6299 | |
John D. L. Nolen, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5808 W 110th St, Overland Park, KS 66211 Phone: 913-696-8000 Fax: 816-302-9939 | |
Dr. William Earl Dorzab, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 7301 College Blvd, Ste. 110, Overland Park, KS 66210 Phone: 913-341-6297 Fax: 913-341-6299 | |
Allison Lisle Cargnel, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 7301 College Blvd, Overland Park, KS 66210 Phone: 913-341-6275 |